| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 11/10/1998 | US5834008 Composition and method for acceleration of wound and burn healing |
| 11/04/1998 | EP0874634A1 Control of healing process |
| 10/28/1998 | EP0873130A2 Compositions comprising pvp having an average molecular weight in the range of 3.000 to 14.000 daltons |
| 10/21/1998 | EP0871458A1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 10/01/1998 | WO1998024427A3 Compositions and methods for treating or preventing inflammatory diseases |
| 09/15/1998 | US5807896 Antiarrhythmia agents; sodium channel modulators; cardiovascular disorders |
| 09/15/1998 | US5807833 Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device |
| 09/09/1998 | CN1192654A Novel embolizing compositions |
| 09/01/1998 | US5800385 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 08/26/1998 | EP0859751A1 Semi-fluorinated alkanes and their use |
| 08/20/1998 | WO1998036075A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 08/20/1998 | CA2280209A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 07/01/1998 | EP0850074A2 Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives |
| 06/25/1998 | WO1998026812A1 A process of composition for medical use |
| 06/25/1998 | CA2247145A1 A process of composition for medical use |
| 06/17/1998 | EP0847240A1 Novel embolizing compositions |
| 06/11/1998 | WO1998024427A2 Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/1998 | CA2607067A1 Compositions and methods for treating or preventing inflammatory diseases |
| 04/23/1998 | WO1998016213A1 Use of sodium 2-mercaptoethanesulfonate in surgery |
| 04/01/1998 | EP0831856A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 03/26/1998 | WO1998011853A1 Composition and method for acceleration of wound and burn healing |
| 03/17/1998 | US5728721 N-(4-trifluoromethyl)-5-methylisoxazole-4-carboxanilide, n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide |
| 03/05/1998 | WO1998008850A1 Spirocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008550A1 Fragmented polymeric hydrogels for adhesion prevention and their preparation |
| 03/05/1998 | CA2264044A1 Spirocyclic metalloprotease inhibitors |
| 03/04/1998 | EP0826373A1 Preventive for postoperative astigmatism |
| 03/04/1998 | CN1175213A Irrigation solution and method for inhibition of pain, inflammation |
| 01/13/1998 | US5708034 Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/06/1998 | US5705488 Injectable compositions for soft tissue augmentation |
| 01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 12/24/1997 | CN1168695A Inhibitor of stem cell proliferation and uses thereof |
| 12/18/1997 | WO1997025052A3 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons |
| 12/04/1997 | WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 12/04/1997 | CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 11/27/1997 | WO1997043899A1 Solution and process for resuscitation and reparation of ischemically damaged tissue |
| 11/12/1997 | EP0730465A4 Use of angiotensin iii and analogs thereof in tissue repair |
| 10/30/1997 | WO1997039765A1 Component b as cicatrizant |
| 10/30/1997 | CA2251356A1 Component b as cicatrizant |
| 10/08/1997 | EP0799055A1 Selective and non-invasive visualization or treatment of vasculature |
| 10/08/1997 | EP0799051A2 Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 08/20/1997 | CN1157569A Anti-adhesion agent |
| 07/30/1997 | CN1155538A Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 07/24/1997 | WO1997025994A1 Control of healing process |
| 07/24/1997 | CA2241983A1 Control of healing process |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/17/1997 | WO1997025052A2 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons |
| 06/24/1997 | US5641792 Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation and pharmaceutical compositions containing them |
| 05/20/1997 | US5631293 Cardiovascular disorders |
| 05/14/1997 | EP0772446A1 Anti-adhesion agent |
| 05/13/1997 | US5629292 Use of angiotensin III and analogs thereof in tissue repair |
| 05/07/1997 | EP0771788A2 Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them |
| 04/10/1997 | WO1997012852A1 Semi-fluorinated alkanes and their use |
| 04/10/1997 | WO1997007833A3 Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives |
| 03/12/1997 | CN1144693A Nerve injury recovery preparation |
| 03/06/1997 | WO1997007833A2 Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/19/1997 | CN1143076A 4-fluoroalkyl substituted phenacyl guanidine, its preparing method, application as medicine or diagnosis agent and medicine containing such compound |
| 02/13/1997 | WO1997004657A1 Novel embolizing compositions |
| 02/06/1997 | WO1997003684A1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 01/23/1997 | WO1996040168A3 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 01/22/1997 | EP0754680A1 4-Fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic as well as medicaments containing them |
| 01/20/1997 | CA2181515A1 4-fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 12/19/1996 | WO1996040168A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 11/14/1996 | WO1996035448A1 Preventive for postoperative astigmatism |
| 10/16/1996 | CN1133562A Injectable compositions for soft tissue augmentation |
| 09/19/1996 | WO1996019233A3 Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 09/11/1996 | EP0730465A1 Use of angiotensin iii and analogs thereof in tissue repair |
| 08/14/1996 | CN1128752A Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines, prepn. method and usage thereof |
| 07/31/1996 | CN1127749A Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 07/03/1996 | EP0719545A1 Thermally reversible and irreversible gels |
| 06/27/1996 | WO1996019233A2 Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 06/26/1996 | EP0717634A1 Injectable compositions for soft tissue augmentation |
| 06/20/1996 | WO1996018415A1 Selective and non-invasive visualization or treatment of vasculature |
| 06/06/1996 | WO1996016653A1 Immunorejection inhibitor |
| 06/04/1996 | US5523291 Implant comprising elastin, collagen and a biocompatible carrier |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/03/1996 | CN1119643A Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their ... |
| 03/20/1996 | EP0702001A1 Fluoro-alkyl/alkenyl-substituted benzoylguanidinens and their use as medicament or diagnostic agent |
| 03/13/1996 | EP0700904A1 Heterocyclic-N-oxide substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, medicaments containing them as well as intermediates for their preparation |
| 03/13/1996 | EP0700899A1 Substituted benzoylguanidines, a process for their preparation, their use as drug or diagnostic agents as well as medicaments containing them |
| 03/06/1996 | EP0699660A2 Arylbenzoylguanidines |
| 03/06/1996 | CN1117962A Arylbenzoylguanidin |
| 03/01/1996 | CA2156960A1 Arylbenzoylguanidines |
| 02/01/1996 | WO1996002258A1 Anti-adhesion agent |
| 12/26/1995 | US5478821 Method of accelerating the proliferation of emdothelial cells with inhibition of no synthases |
| 07/05/1995 | EP0660719A1 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 06/13/1995 | US5424298 Topical powder compositions containing a cyclic AMP derivative |
| 04/11/1995 | US5405838 Topical powder compositions containing a cyclic AMP derivative |
| 03/30/1995 | WO1995008337A1 Use of angiotensin iii and analogs thereof in tissue repair |
| 03/16/1995 | WO1995007095A1 Injectable compositions for soft tissue augmentation |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 01/04/1995 | EP0631776A1 Use of beta-naphthoquinone for accelerating the proliferation of endothelial cells and inhibiting no synthases |
| 03/16/1994 | EP0586535A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 02/15/1994 | US5286718 Administering monophosphoryl lipid A or its 3-deacylated derivative |
| 01/19/1994 | CN1080873A Application of inhibitor of plasmin aktivator in treatment of inflammation and trauma |
| 01/11/1994 | US5277907 Regulation of the immune system |
| 11/03/1993 | EP0567816A1 Use of inhibitors of plasminogen activators for treating of inflammations and wounds |
| 10/31/1993 | CA2095207A1 Use of inhibitors of plasminogen activators for the treatment of inflammations and wounds |
| 10/28/1993 | WO1993020696A1 Regulation of the immune system |
| 07/08/1993 | WO1993012778A1 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |